Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Journal of King Saud University - Computer and Information Sciences | journal | 0.793 Q1 | 60 | 48 | 135 | 2087 | 879 | 129 | 7.29 | 43.48 | 21.50 | |
2 | Applied Computing and Informatics | journal | 0.792 Q1 | 38 | 25 | 79 | 896 | 464 | 78 | 5.40 | 35.84 | 26.56 | |
3 | Journal of the Saudi Society of Agricultural Sciences | journal | 1.063 Q1 | 58 | 63 | 130 | 2485 | 716 | 130 | 5.32 | 39.44 | 20.64 | |
4 | Journal of King Saud University, Engineering Sciences | journal | 0.764 Q1 | 55 | 49 | 132 | 1176 | 625 | 126 | 4.76 | 24.00 | 17.31 | |
5 | Current Neuropharmacology | journal | 1.531 Q1 | 103 | 84 | 319 | 11035 | 1560 | 286 | 4.51 | 131.37 | 42.98 | |
6 | Egyptian Journal of Petroleum | journal | 1.044 Q1 | 61 | 47 | 303 | 1695 | 1565 | 303 | 4.03 | 36.06 | 15.32 | |
7 | Current Medicinal Chemistry | journal | 0.903 Q1 | 202 | 432 | 892 | 53007 | 3275 | 828 | 3.62 | 122.70 | 44.94 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 0.832 Q2 | 96 | 75 | 356 | 5805 | 1004 | 308 | 3.28 | 77.40 | 42.50 | |
9 | Prostate Cancer | journal | 0.703 Q2 | 15 | 10 | 18 | 261 | 49 | 17 | 3.20 | 26.10 | 23.33 | |
10 | Journal of Immunology Research | journal | 1.163 Q1 | 113 | 261 | 783 | 14874 | 2823 | 744 | 3.18 | 56.99 | 48.50 | |
11 | International Journal of Hepatology | journal | 0.760 Q2 | 20 | 4 | 29 | 128 | 88 | 29 | 3.16 | 32.00 | 36.36 | |
12 | Current Alzheimer Research | journal | 1.079 Q2 | 103 | 114 | 418 | 8631 | 1424 | 390 | 3.15 | 75.71 | 44.92 | |
13 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.755 Q1 | 29 | 18 | 71 | 0 | 180 | 68 | 3.11 | 0.00 | 42.05 | |
14 | Cardiovascular Psychiatry and Neurology | journal | 0.313 Q3 | 27 | 0 | 4 | 0 | 11 | 4 | 3.00 | 0.00 | 0.00 | |
15 | Journal of Diabetes Research | journal | 0.988 Q2 | 83 | 235 | 888 | 9624 | 2891 | 859 | 2.99 | 40.95 | 47.99 | |
16 | Current Topics in Medicinal Chemistry | journal | 0.788 Q2 | 133 | 231 | 798 | 22201 | 2546 | 687 | 2.90 | 96.11 | 40.28 | |
17 | Current Molecular Pharmacology | journal | 0.629 Q2 | 49 | 28 | 98 | 2442 | 237 | 85 | 2.87 | 87.21 | 44.53 | |
18 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.603 Q2 | 52 | 29 | 94 | 2940 | 250 | 91 | 2.75 | 101.38 | 44.35 | |
19 | Complexity | journal | 0.507 Q1 | 79 | 673 | 1261 | 26759 | 3364 | 1230 | 2.70 | 39.76 | 30.97 | |
20 | Current Genomics | journal | 0.766 Q3 | 77 | 60 | 165 | 3531 | 435 | 146 | 2.68 | 58.85 | 37.33 | |
21 | Ain Shams Engineering Journal | journal | 0.402 Q1 | 76 | 89 | 465 | 2832 | 1336 | 465 | 2.67 | 31.82 | 20.30 | |
22 | Mini-Reviews in Medicinal Chemistry | journal | 0.500 Q2 | 107 | 120 | 425 | 10067 | 1162 | 394 | 2.65 | 83.89 | 36.87 | |
23 | Current Drug Targets | journal | 0.741 Q2 | 119 | 139 | 552 | 15568 | 1470 | 500 | 2.63 | 112.00 | 40.24 | |
24 | Current Cancer Drug Targets | journal | 0.893 Q1 | 103 | 81 | 240 | 6341 | 652 | 219 | 2.62 | 78.28 | 42.96 | |
25 | Egyptian Journal of Aquatic Research | journal | 0.516 Q2 | 50 | 53 | 146 | 1942 | 383 | 146 | 2.54 | 36.64 | 32.52 | |
26 | Stroke Research and Treatment | journal | 0.739 Q2 | 43 | 12 | 55 | 376 | 136 | 55 | 2.53 | 31.33 | 27.27 | |
27 | Advances in Bioinformatics | journal | 0.390 Q3 | 26 | 5 | 36 | 210 | 74 | 36 | 2.50 | 42.00 | 43.75 | |
28 | International Journal of Genomics | journal | 0.798 Q1 | 37 | 65 | 212 | 3700 | 537 | 205 | 2.46 | 56.92 | 47.02 | |
29 | Current Stem Cell Research and Therapy | journal | 0.577 Q2 | 63 | 95 | 228 | 6944 | 521 | 204 | 2.43 | 73.09 | 40.11 | |
30 | International Journal of Microbiology | journal | 0.644 Q3 | 59 | 47 | 137 | 2042 | 352 | 136 | 2.39 | 43.45 | 40.44 | |
31 | Current Protein and Peptide Science | journal | 0.666 Q2 | 96 | 121 | 329 | 11284 | 727 | 291 | 2.31 | 93.26 | 39.55 | |
32 | Karbala International Journal of Modern Science | journal | 0.334 Q2 | 29 | 31 | 108 | 910 | 282 | 108 | 2.30 | 29.35 | 25.32 | |
33 | Current Gene Therapy | journal | 0.782 Q2 | 80 | 44 | 128 | 2998 | 283 | 115 | 2.29 | 68.14 | 40.22 | |
34 | Medicinal Chemistry | journal | 0.344 Q3 | 50 | 82 | 254 | 4430 | 481 | 248 | 2.24 | 54.02 | 43.45 | |
35 | Current Pharmaceutical Design | journal | 0.606 Q2 | 183 | 450 | 1768 | 47168 | 4305 | 1639 | 2.23 | 104.82 | 42.01 | |
36 | Canadian Journal of Gastroenterology and Hepatology | journal | 0.727 Q2 | 76 | 79 | 286 | 2801 | 622 | 265 | 2.19 | 35.46 | 35.64 | |
37 | Current Radiopharmaceuticals | journal | 0.447 Q3 | 32 | 34 | 90 | 1777 | 173 | 82 | 2.19 | 52.26 | 35.80 | |
38 | Journal of Nutrition and Metabolism | journal | 0.637 Q2 | 57 | 51 | 130 | 2170 | 321 | 128 | 2.17 | 42.55 | 51.61 | |
39 | Analytical Cellular Pathology | journal | 0.534 Q2 | 35 | 51 | 78 | 2067 | 172 | 78 | 2.16 | 40.53 | 42.24 | |
40 | Journal of Advanced Transportation | journal | 0.569 Q1 | 62 | 213 | 611 | 7641 | 1343 | 599 | 2.16 | 35.87 | 31.16 | |
41 | Current Vascular Pharmacology | journal | 0.559 Q2 | 69 | 51 | 261 | 3613 | 489 | 216 | 2.13 | 70.84 | 34.62 | |
42 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.465 Q3 | 63 | 137 | 157 | 7351 | 291 | 152 | 2.08 | 53.66 | 46.86 | |
43 | Pulmonary Medicine | journal | 0.566 Q2 | 39 | 16 | 27 | 740 | 62 | 27 | 2.08 | 46.25 | 31.25 | |
44 | Current Diabetes Reviews | journal | 0.687 Q2 | 68 | 67 | 177 | 3411 | 403 | 164 | 2.04 | 50.91 | 42.98 | |
45 | Hematology/ Oncology and Stem Cell Therapy | journal | 0.580 Q2 | 30 | 39 | 136 | 937 | 252 | 136 | 2.03 | 24.03 | 37.66 | |
46 | Applied Computational Intelligence and Soft Computing | journal | 0.264 Q3 | 22 | 3 | 44 | 132 | 131 | 42 | 2.02 | 44.00 | 37.50 | |
47 | Current Organic Synthesis | journal | 0.330 Q3 | 55 | 82 | 252 | 5517 | 475 | 242 | 2.02 | 67.28 | 40.15 | |
48 | Journal of Toxicology | journal | 0.491 Q3 | 47 | 24 | 77 | 1202 | 189 | 77 | 2.02 | 50.08 | 34.35 | |
49 | Anemia | journal | 0.565 Q3 | 31 | 7 | 28 | 198 | 63 | 28 | 2.00 | 28.29 | 34.62 | |
50 | Depression Research and Treatment | journal | 0.932 Q1 | 36 | 4 | 32 | 154 | 90 | 30 | 2.00 | 38.50 | 10.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®